Dr. Fiaz Zaman, MD

Dr. Zaman practices at Houston Eye Surgery Center in Houston, Texas.

Dr. Zaman's NPI, 1073508164, was assigned on September 14, 2005. Dr. Zaman graduated from UMKC School of Medicine in 1995. Dr. Zaman's Texas license number on file is K2391.

Dr. Zaman's primary practice is Houston Eye Surgery Center, at 2855 Gramercy St, Houston, TX 77025 in Harris County. The practice phone is (832) 553-7171.

Dr. Zaman's primary practice is Houston Eye Surgery Center in Houston, Texas. Dmand AI also links Dr. Zaman to 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zaman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zaman is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Zaman has a license on file in Texas.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Zaman treats.

CMS data shows 3,359 Medicare services from Dr. Zaman across 17 procedure codes in 2024, for 1,143 Medicare patients. Medicare paid $267,782 for them.

CMS counts 1,143 Medicare patients who saw Dr. Zaman in 2024. The largest group is 75 to 84, with 458 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zaman's median patient age at 73, with 57% women.

In 2024, Dr. Zaman wrote 9,916 Medicare Part D claims for 1,725 patients. 38% of them were for generic drugs. CMS names the drug for 9,823 of them, across 41 drugs with 11 or more claims each, at $2,505,508 in total drug cost. In 2023, CMS named 9,204 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zaman for performance year 2024, reported as part of a group. Dr. Zaman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 212 procedures of cataract surgery by Dr. Zaman, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Zaman, published from 2011 to 2021. 2021 was the busiest year, with 2. Dr. Zaman's most frequent co-authors are Steven D. Vold, MD, Stephen C. Gieser, MD and Gail Faith Schwartz, MD.

CMS Open Payments shows 806 general payments to Dr. Zaman from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Allergan Inc. paid the most, $108,800. It also lists 1 research payment totaling $1,500 in 2025.

Dr. Zaman graduated from UMKC School of Medicine in 1995.

Dr. Zaman is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.